Connect with us

Hi, what are you looking for?

Wednesday, Jun 29, 2022
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.

Business

Valens to manufacture pre-rolls and vapes for MTL Cannabis

The manufacturing partnership is set to start near the end of the first quarter of fiscal 2022

Valens to manufacture pre-rolls and vapes for MTL Cannabis
While MTL Cannabis will soon have more cultivation space, the firm's CEO looks forward to the Valens partnership to expand product offerings in a variety of formats. Image via MTL Cannabis

Cannabis producer The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) will be handling the manufacturing and extracting for Montreal Cannabis Médical Inc.’s pre-rolls and vapes through a new partnership.

In a statement Wednesday, the Kelowna-based firm says the manufacturing partnership with privately-owned MTL Cannabis is expected to begin near the end of the first quarter of fiscal 2022.

“MTL has demonstrated the kind of success, consistency and quality that The Valens Company looks for in a partner,” says Valens CEO Tyler Robson. “We are excited to expand our presence with one of the fastest-growing and reputable flower consumer brands in Canada.”

Read more: Valens gets $40M loan to accelerate growth

Described as a flower-first company, MTL Cannabis is among the top five in dried flower sales in most provides, according to the statement.

Valens set to acquire Citizen Stash for $54.3M - extraction

Valens is a leading Canadian extractor. Photo via Valens

Around the same time the manufacturing deal is set to start, the reverse takeover of Canada House Wellness Group (CSE: CHV) by MTL Cannabis is expected to close, giving the Quebec-based producer more cultivation space and more than doubling its annual production capacity.

The producer will go from its 57,000-square-foot footprint and annual production capacity of 13,000 kilograms of dried flower to 120,000 square feet and 30,000 kilograms of annual production.

Read more: MTL Cannabis RTO of Canada House to close early 2022

While MTL Cannabis has the space, CEO Richard Clement says the firm looks forward to the Valens partnership to expand product offerings in a variety of formats.

“Valens not only has one of the broadest ranges of manufacturing capabilities but also shares the same commitment to consumers and quality that we do,” he says.

On Wednesday, Valens stock was flat around $3.34 on the Toronto Stock Exchange.

Read more: Valens enters Mexico via drug supplier to distribute CBD and succulent-based powder

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Kathryn Tindale on Twitter

kathryn@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published.

You May Also Like

Health and Safety

Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can

Canada

As more medium-to-small producers came into play this year, great weed started hitting legal shelves at fairer prices

Culture

Punishments for possession include caning and the death penalty. Despite a global trend of reform, The Fine City remains staunch in its anti-drug stance

Analysis

While legal weed businesses decry enforcement of their accounts, the platform says it's keeping its all-ages community safe